Back

Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Oral anticoagulation in real life Oral Anticoagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christopher Olesovsky

University of Toronto, Toronto (Canada)

7 More presentations in this session

Presentation thumbnail
Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: A nationwide cohort study
Associate Professor D. Pastori (Rome, IT)
Abstract Slides
Presentation thumbnail
Body mass index from the RE-LY trial: further evidence of the obesity paradox
Doctor M. Jacobs (Stony Brook, US)
Abstract Slides
Presentation thumbnail
Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study
Doctor A. Shantsila (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry
Professor H. Yu (Seoul, KR)
Abstract Slides
Presentation thumbnail
Comparative validation of the HAS-BLED and the GARFIELD-AF bleeding risk scores in Asian patients with atrial fibrillation: a report from the COOL-AF registry
Doctor P. Chichareon (Hat Yai, TH)
Abstract Slides

Access the full session

Session thumbnail
Oral anticoagulation in real life

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources